Suppr超能文献

多巴胺能、5-羟色胺能和谷氨酸能受体在迟发性运动障碍中发挥机制性作用的可能性:两个独立患者群体的基因变异比较

Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populations.

作者信息

Ivanova Svetlana A, Loonen Anton Jm, Bakker P Roberto, Freidin Maxim B, Ter Woerds Nienke J, Al Hadithy Asmar Fy, Semke Arkadiy V, Fedorenko Olga Yu, Brouwers Jacobus Rbj, Bokhan Nikolay A, van Os Jim, van Harten Peter N, Wilffert Bob

机构信息

Mental Health Research Institute, Tomsk, Russian Federation; National Research Tomsk Polytechnic University, Tomsk, Russian Federation.

Department of Pharmacy, University of Groningen, Groningen, The Netherlands; GGZ Westelijk Noord-Brabant, Bergen op Zoom, The Netherlands.

出版信息

SAGE Open Med. 2016 Apr 11;4:2050312116643673. doi: 10.1177/2050312116643673. eCollection 2016.

Abstract

OBJECTIVES

An established theory for the pathogenesis of tardive dyskinesia is disturbed dopaminergic receptor sensitivity and/or dopaminergic intracellular signaling. We examined associations between genetic variants of neurotransmitter receptors and tardive dyskinesia.

METHODS

We assessed tardive dyskinesia in Caucasian psychiatric inpatients from Siberia (N = 431) and a long-stay population from the Netherlands (N = 168). These patients were genotyped for 43 tag single nucleotide polymorphisms in five neurotransmitter receptor genes, and the results for the two populations were compared.

RESULTS

Several significant associations with tardive dyskinesia were identified, but only GRIN2A (rs1345423) was found in both patient populations. This lack of agreement was probably due to the small effect size of the associations, the multiple testing and the small sample size of the Dutch patient population. After reviewing the literature, we propose that the constitutive stimulatory activity of serotonergic type 2 receptors may be relevant.

CONCLUSIONS

Inactivity of the serotonergic, type 2C receptor or blockade of these receptors by atypical antipsychotic drugs may decrease the vulnerability to develop tardive dyskinesia.

摘要

目的

迟发性运动障碍发病机制的一个既定理论是多巴胺能受体敏感性和/或多巴胺能细胞内信号传导受到干扰。我们研究了神经递质受体基因变异与迟发性运动障碍之间的关联。

方法

我们评估了来自西伯利亚的白种人精神科住院患者(N = 431)和来自荷兰的长期住院人群(N = 168)的迟发性运动障碍。对这些患者的五个神经递质受体基因中的43个标签单核苷酸多态性进行基因分型,并比较了两个群体的结果。

结果

确定了与迟发性运动障碍的几个显著关联,但仅在两个患者群体中都发现了GRIN2A(rs1345423)。这种不一致可能是由于关联的效应量小、多重检验以及荷兰患者群体的样本量小。在查阅文献后,我们提出血清素能2型受体的组成性刺激活性可能与之相关。

结论

血清素能2C型受体的无活性或非典型抗精神病药物对这些受体的阻断可能会降低发生迟发性运动障碍的易感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/619d/4834466/8f026a750d3f/10.1177_2050312116643673-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验